Price T Rowe Associates Inc. MD Buys 25,272 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• Price T Rowe Associates Inc. MD increased its holdings in Mettler-Toledo International, Inc. by 5.5%, now owning 481,011 shares, valued at approximately $568 million.
• Research firms have updated their price targets for Mettler-Toledo, with Bank of America raising its target from $1,200 to $1,260 and maintaining a "neutral" rating.
• Mettler-Toledo International reported an earnings per share (EPS) of $10.09 for the last quarter, beating estimates and showing 3.9% revenue growth year-over-year.

Price T Rowe Associates Inc. MD boosted its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 5.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 481,011 shares of the medical instruments supplier's stock after acquiring an additional 25,272 shares during the period. Price T Rowe Associates Inc. MD owned 2.31% of Mettler-Toledo International worth $568,032,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in MTD. Farther Finance Advisors LLC increased its position in Mettler-Toledo International by 39.1% during the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock worth $103,000 after buying an additional 25 shares during the period. QRG Capital Management Inc. increased its position in Mettler-Toledo International by 29.4% during the 1st quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock worth $577,000 after buying an additional 111 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its position in Mettler-Toledo International by 13.3% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock worth $2,929,000 after buying an additional 292 shares during the period. Wealth Enhancement Advisory Services LLC increased its position in Mettler-Toledo International by 95.0% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock worth $2,600,000 after buying an additional 1,073 shares during the period. Finally, Boston Trust Walden Corp increased its position in Mettler-Toledo International by 7.1% during the 1st quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier's stock worth $40,871,000 after buying an additional 2,296 shares during the period. Institutional investors own 95.07% of the company's stock.

Insider Transactions at Mettler-Toledo International

In other news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the sale, the director directly owned 120 shares of the company's stock, valued at approximately $139,191.60. This trade represents a 89.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the sale, the director directly owned 283 shares in the company, valued at $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 2,889 shares of company stock valued at $3,603,054. Company insiders own 0.77% of the company's stock.

Mettler-Toledo International Price Performance

NYSE:MTD traded down $31.57 during trading hours on Monday, hitting $1,289.88. The company's stock had a trading volume of 85,847 shares, compared to its average volume of 164,695. The stock has a fifty day simple moving average of $1,229.78 and a 200-day simple moving average of $1,186.02. The company has a market capitalization of $26.57 billion, a P/E ratio of 32.66, a PEG ratio of 3.97 and a beta of 1.34. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same period last year, the firm posted $9.65 earnings per share. The business's revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently issued reports on MTD shares. Robert W. Baird increased their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Wells Fargo & Company increased their target price on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a report on Monday, May 5th. Wall Street Zen lowered Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their target price for the stock from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Finally, Citigroup increased their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $1,311.11.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.